Apellis Pharmaceuticals Inc (NASDAQ: APLS) Bullish Outlook Still Prevails With Short Term Targets At $57
Apellis Pharmaceuticals Inc (NASDAQ:APLS) does about 1.81M shares in volume on a normal day but saw 2394624 shares change hands in the recent trading day. The company now has a market cap of 2.75B USD. Its current market price is $21.87, marking a decrease of -9.89% compared to the previous close of $24.27. The 52 […]
Apellis Pharmaceuticals Inc (NASDAQ: APLS): Think Like A Lender, Not An Investor
Apellis Pharmaceuticals Inc (NASDAQ:APLS) currently has a daily average trading volume of 1.75M but it saw 2788271 shares traded in last market. With a market cap of 3.05B USD, the company’s current market price of $24.28 came rising about 2.06 while comparing to the previous closing price of $23.79. In past 52 weeks, the stock […]
Apellis Pharmaceuticals Inc (NASDAQ: APLS) Gets A 57.44% Target Price Upside From Analysts While 2.06% Above Its 52-Week Low
Apellis Pharmaceuticals Inc (NASDAQ:APLS) does about 1.71M shares in volume on a normal day but saw 1911690 shares change hands in the recent trading day. The company now has a market cap of 3.05B USD. Its current market price is $24.26, marking an increase of 0.50% compared to the previous close of $24.14. The 52 […]
Apellis Pharmaceuticals Inc (APLS) Down -58.59% From Its 52-Week High, But Growth Potential Is Changing Over Time
Apellis Pharmaceuticals Inc (NASDAQ:APLS) currently has a daily average trading volume of 1.73M but it saw 1910542 shares traded in last market. With a market cap of 3.11B USD, the company’s current market price of $24.81 came rising about 1.64 while comparing to the previous closing price of $24.41. In past 52 weeks, the stock […]
